WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and specificity endpoints, according to results from the PREEMPT CRC study. Using ...
Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial This epidemiological ...
Morning Overview on MSN
Photonics and nanotech may detect cancer signals 5 to 8 years early
Scientists working at the intersection of photonics and nanotechnology are building tools that could identify cancer-related signals in blood samples collected five to eight years before a clinical ...
AI-supported mammography screening shows consistently favourable outcomes when contrasted with standard double reading.
A new recommendation from the American Headache Society calls for annual migraine screening as part of preventive care for girls and women — from adolescence through menopause.
Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that ...
The FDA approved the Shield blood test for colorectal cancer (CRC) screening in adults ages 45 and older at average risk for the disease, Guardant Health announced. According to the company, the ...
A young woman steps nervously into a makeshift screening tent. Inside, a small tripod-mounted thermal camera waits. Asked to place her hands behind her head, sh ...
Good day, ladies and gentlemen, and welcome to today's GRAIL analyst call. [Operator Instructions] Please be advised that this conference call is being recorded. GRAIL Investor Relations. Please begin ...
A machine learning-driven eNose detects ovarian cancer in blood plasma with 97 % sensitivity and specificity, offering a promising biomarker-agnostic approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results